← Back to Search

Contact Lens

MiSight 1 Day Contact Lenses for Nearsightedness

N/A

Recruiting

Led By William Gleason, OD

Research Sponsored by Coopervision, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Free of ocular disease or abnormalities (including any corneal scar)

Be between 8 and 12 years of age inclusive at the time of enrollment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 years

Awards & highlights

Study Summary

This trial will test the effectiveness of the MiSight 1 Day lens in reducing myopia (nearsightedness) in children in the real world.

Who is the study for?

This trial is for children aged 8-12 with near-sightedness, having a specific range of vision error and good overall health. They must be willing to wear contact lenses daily for about 10 hours, follow the study's schedule for 4 years, and not have any eye diseases or conditions that could interfere with contact lens use.Check my eligibility

What is being tested?

The MiSight 1 Day contact lens is being tested against Proclear 1 day lenses to confirm its effectiveness in reducing myopia in kids when used in everyday life. The study will monitor changes over one year post-treatment.See study design

What are the potential side effects?

While not explicitly listed, potential side effects may include discomfort while wearing the lenses, redness or irritation of the eyes, dry eyes, allergic reactions to lens material or solutions used with them.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My eyes are healthy and free from any diseases or scars.

Select...

I am between 8 and 12 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean difference in axial length change from baseline

Mean difference in cycloplegic SERE change from baseline

Mean difference in rate of axial length - Part 2 study

+1 more

Secondary outcome measures

Percentage of subjects with no appreciable myopic progression

Visual symptoms and the effects on activities of daily living

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: MiSight 1 dayExperimental Treatment1 Intervention

MiSight 1 day

Group II: Proclear 1 dayActive Control1 Intervention

Proclear 1 day

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Coopervision, Inc.Lead Sponsor

156 Previous Clinical Trials

12,969 Total Patients Enrolled

William Gleason, ODPrincipal InvestigatorForesight Regulatory Strategies, Inc. (FRS)

3 Previous Clinical Trials

2,958 Total Patients Enrolled

Media Library

MiSight 1 Day (Contact Lens) Clinical Trial Eligibility Overview. Trial Name: NCT05285553 — N/A

Near-sightedness Research Study Groups: MiSight 1 day, Proclear 1 day

Near-sightedness Clinical Trial 2023: MiSight 1 Day Highlights & Side Effects. Trial Name: NCT05285553 — N/A

MiSight 1 Day (Contact Lens) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05285553 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this experiment open to individuals over the age of 25?

"The age requirements for participants in this clinical trial are rather specific; potential patients must be between 8 and 12 years of age."

Answered by AI

How many people are engaging in this clinical endeavor?

"This investigation requires 900 consenting individuals that match the mentioned criteria. Participants can come to either New England College of Optometry in Boston or Cornea & Contact Lens Institute of Minnesota in Edina, two esteemed locations for this trial."

Answered by AI

To whom is this experimental program available?

"This clinical trial requires myopic participants aged between 8 and 12 to join. With 900 spots available, the study is actively recruiting a sizeable cohort of patients."

Answered by AI

What is the scope of this medical experiment, in terms of number and type of locations?

"Currently, 5 trial sites are recruiting participants for this clinical study. These locations include Boston, Edina and Granville as well as other nearby medical centres; thus it is important to pick the nearest site in order to reduce any inconvenience caused by travel."

Answered by AI

Are enlistments still being taken for this clinical trial?

"Clinicaltrials.gov reveals that this clinical trial, first advertised on June 25th 2022, is currently searching for participants with its most recent update taking place August 1st 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms

2022. "MiSight 1 Day Post-Approval Study for Effectiveness and Visual Symptoms". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05285553.

All > Myopia